PACB Pacific Biosciences of California
Company Analysis
Latest News
🟢 Pacific Biosciences is trading 5.7% up; no clear catalyst identified
Pacific Biosciences is trading 5.7% higher at $1.81 on September 29, 2026, with no new company-specific announcement identified to explain the move. - A...
🟢 Pacific Biosciences is trading 10.2% up
Pacific Biosciences is trading at $1.78, up 10.19%, with no clear company-specific catalyst identified for the September 28, 2026 rise. - Recent coverage of...
🟢 Pacific Biosciences is trading 7.1% up with no clear company-specific catalyst identified
Pacific Biosciences is trading at $1.74, up 7.10%, with no clear company-specific explanation for its September 28 rise identified in the search. - Recent...
🟢 Pacific Biosciences is trading 10.6% up today with no clear catalyst identified
Pacific Biosciences is trading 10.64% higher at $1.56, with no clear company-specific catalyst identified for September 24, 2026. - The biotechnology sector is...
🟢 Pacific Biosciences is trading 6% up today with no identified catalyst
Pacific Biosciences is trading 6.03% higher at $1.50, with no confirmed catalyst identified. - No September 24, 2026 earnings, regulatory, partnership,...
🔴 Pacific Biosciences is trading 5% down today amid rising yields and biotech-sector losses
Pacific Biosciences is trading at $1.40, down 5.10%, as broad risk-off pressure weighs on growth-oriented biotech stocks. - Rising crude oil and Treasury...
🟢 Pacific Biosciences is trading 5.9% up today amid sector-driven biotech strength
Pacific Biosciences is trading 5.9% up at $1.44, apparently on sector-driven biotech and technology strength. - The Nasdaq Biotechnology Index rose 1.10% on...
🟢 Pacific Biosciences rises 5.6% — Biotech Sector Rallies on Strong Industry Outlook and M&A Optimism
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as measured by the XBI ETF,...
🟢 Pacific Biosciences is trading 5% up today with no clear company-specific catalyst
Pacific Biosciences is trading $1.37, up 5.32%, with no clear company-specific announcement explaining the September 14, 2026 move. - Management is scheduled...
🔴 Pacific Biosciences is trading 5.2% down today amid risk-off sentiment from Middle East tensions
Pacific Biosciences is trading 5.2% down at $1.28 as the broader market and biotechnology sector weaken. - On September 1, 2026, risk-off sentiment reflects...
🔴 Pacific Biosciences falls 5.2% — Biotech Sector Declines Amid Fed Rate Hike Fears
With Biotech (XBI) down 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...
🟢 Pacific Biosciences is trading 5% up today as biotechnology stocks and XBI rise broadly
Pacific Biosciences is trading 5.26% up now at $1.60, extending its recent rebound after an 18.75% gain on August 25, with sector momentum driving broad gains...
🟢 Pacific Biosciences is trading 11% up today amid broad biotechnology-sector strength
Pacific Biosciences is trading 10.94% up now at $1.42 as biotechnology shares strengthen broadly. - No company-specific announcement dated August 25, 2026,...
🟢 Pacific Biosciences is trading 7% up today as XBI gains 2.06%
Pacific Biosciences is trading at $1.37 (+7.03%) as biotech strength, XBI’s 2.06% rise, and a broader risk-on backdrop support the move. - No company-specific...
🔴 Pacific Biosciences is trading 5% down today; catalyst remains unclear
Pacific Biosciences is trading 5.01% down at $1.28, with no new company-specific announcement identified to explain the August 24, 2026 decline. - Recent...
🟢 Pacific Biosciences is trading 10% up today as biotech stocks rally on clinical-news momentum
Pacific Biosciences is trading 10.16% up at $1.35, with the move appearing primarily sector-driven as biotechnology stocks rally alongside positive...
🟢 Pacific Biosciences rises 5.2% — Biotech Sector Continues Upward Trend on Strong Momentum
With Biotech (XBI) up 2.0%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as measured by the XBI ETF,...
🟢 Pacific Biosciences is trading 13.17% up today after positive Phase 3 melanoma-vaccine results
Pacific Biosciences is trading 13.17% up now at $1.29 after positive Phase 3 melanoma cancer-vaccine results from Moderna and Merck lifted biotechnology-sector...
🟢 Pacific Biosciences is trading 7.94% up today following positive late-stage melanoma cancer-vaccine results
Pacific Biosciences is trading 7.94% up at $1.22 as biotech shares rally following positive late-stage melanoma cancer-vaccine results from Moderna and...
🔴 Pacific Biosciences is trading 5.8% down today amid broader market declines
Pacific Biosciences is trading 5.8% down at $1.14, amid a broader risk-off session with no clear company-specific announcement identified for August 18,...